RSI Technology Group
RSI Technology Group (dba Reproductive Solutions) is a privately held medical device company that develops and sells the ProteX semen collection cup and NovoSort sperm preparation device to fertility clinics, IVF centers, and patients across the United States and Canada.
- Company typePrivate
- Founded2009
- HeadquartersFrisco, United States
- Headcount—
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What RSI Technology Group does
RSI Technology Group LLC, doing business as Reproductive Solutions, is a privately held medical device company founded in 2009 and headquartered in Lubbock, Texas, that develops and commercializes proprietary devices for sperm collection and preparation in fertility care. The company was originally formed to license semen-collection and preservation technology developed at Texas Tech University by co-founders Dr. Samuel Prien, Dr. Dustie Johnson, and Dr. Lindsay Penrose, alongside John Smothers, and was relaunched in 2017 through the Texas Tech Innovation Hub's Accelerator program. The product portfolio centers on the ProteX™ Semen Collection Cup — a triple-layer insulated device with a proprietary Safe Seal™ designed to maintain sperm sample integrity for up to 24 hours — and the NovoSort® Sperm Isolation Device, a passive, centrifuge-free sperm preparation device that integrates directly with the ProteX cup to create a closed, one-step collection-to-preparation workflow. Co-founder Dr. Prien holds seven U.S. patents and twenty-two international patents, and Dr. Penrose holds four U.S. patents and two international patents, anchoring a defensible IP estate around the integrated system.
RSI monetizes primarily through hardware sales of medical devices to fertility clinics and IVF centers, with publicly disclosed pricing of $1,500 per case of 25 ProteX cups and $1,500 per NovoSort device individually, and $1,875 for the integrated combo system, with bulk discounts available. Distribution is hybrid: direct sales to providers supported by a dedicated 'Schedule a Call' CTA, direct-to-consumer e-commerce through tryprotex.com, and reseller relationships with fertility pharmacies (Hann's Fertility Pharmacy, Mandell's Pharmacy, Pixel Care Health) and specialty andrology distributors (Andrology Store, IVF Store, Fertitech Canada). The company targets three primary customer segments — fertility clinics and healthcare providers, individual patients and couples pursuing fertility treatment, and the LGBTQIA+ community — and supports this with inclusive marketing, the r/RSIProteX subreddit community, and a partnership with LGBTQIA+ advocacy organization Families Out Loud. Operating geographies span the United States and Canada, with no disclosed revenue, headcount, or institutional funding beyond 2017 grant proceeds.
RSI Technology Group firmographics
Firmographics- Name
- RSI Technology Group
- Legal name
- RSI Technology Group LLC
- Website
- https://rsifertility.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Short description
- RSI Technology Group (dba Reproductive Solutions) is a privately held medical device company that develops and sells the ProteX semen collection cup and NovoSort sperm preparation device to fertility clinics, IVF centers, and patients across the United States and Canada.
- Ownership category
- akta.pro rank
RSI Technology Group industry classification
Industry- Product category
- Fertility Medical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Male Reproductive & Sexual Medicine (Andrology) (HLAKAOAD)
Keywords
Where RSI Technology Group is headquartered
LocationHeadquarters
- HQ city
- Frisco
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
RSI Technology Group business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales
Revenue model
- Medical Device Sales: RSI generates revenue through the sale of proprietary medical devices. Products are sold directly to fertility clinics and providers, as well as through online channels for patients. Pricing is on a per-unit basis with bulk case discounts available.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | ProteX Semen Collection Cup with Safe Seal – Case of 25 |
| Unit Pricing | Pay-as-you-go | NovoSort Sperm Isolation Device Only |
| Unit Pricing | Pay-as-you-go | NovoSort + ProteX Combo System |
| Unit Pricing | Pay-as-you-go | Door Hangers (Set of 3) |
| Unit Pricing | Pay-as-you-go | ProteX & NovoSort Combo Sample |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels5 records
RSI Technology Group product offering
Product offeringCore offering
RSI Technology Group designs, manufactures, and sells proprietary medical devices for sperm collection and preparation in fertility care. Its flagship products — the ProteX Semen Collection Cup with triple-layer insulation and Safe Seal, and the NovoSort passive, centrifuge-free Sperm Preparation Device — are sold as an integrated collection-to-preparation system to fertility clinics, IVF centers, and patients. Devices are priced per unit with bulk case discounts available and are sold through direct sales, the company's e-commerce site, and partner pharmacies.
Product overview
RSI Technology Group offers a dual-product portfolio centered on male fertility care: ProteX™ Semen Collection Cup and NovoSort® Sperm Isolation Device. These products are designed to work together as an integrated system—the ProteX cup serves as the collection vessel with triple-layer insulation for temperature stability, while NovoSort is a passive, centrifuge-free sperm preparation device that processes samples directly within the ProteX cup. The combined ProteX and NovoSort system eliminates sample transfers, supports chain of custody, and reduces handling steps from collection through preparation. Products are available for both clinical and at-home use, targeting fertility clinics, IVF centers, and patients. Pricing ranges from accessories at $9.99 to clinical device combinations at $1,500-$1,875.
Differentiator
Problem solved
Functional benefit
Brands
- ProteX: ProteX Semen Collection Cup - A triple-insulated sperm collection system designed to support sperm quality, comfort, and flexible collection in both at-home and in-clinic settings.
- NovoSort
Products and services
- NovoSort Sperm Isolation Device and ProteX Collection Cup with Safe Seal Combo An integrated system combining ProteX with Safe Seal and NovoSort into a single streamlined workflow from collection through preparation. NovoSort processes sperm directly within the ProteX cup, eliminating transfers and enabling true one-step processing while supporting a secure chain of custody. Priced at $1,875.00 per unit.
- ProteX Semen Collection Cup with Safe Seal — Case of 25 A triple-layer insulated sperm collection cup designed to maintain optimal environment during semen collection and handling. Helps protect samples from temperature shock during both at-home and in-clinic use. Case of 25 priced at $1,500.00 with bulk discount available.
- NovoSort Sperm Isolation Device Only A passive, centrifuge-free sperm isolation device designed to integrate directly with the ProteX collection cup. Reduces handling steps and processing time, supporting a secure chain of custody. Priced at $1,500.00. Available for licensed physicians and IVF clinics.
- ProteX & NovoSort Sperm Isolation Device Combo Sample A 2-pack of sterilized samples (NovoSort and ProteX cups) available at no cost for registered clinics or physician offices. Sample requests must include official email address and physical address.
- Door Hangers (Set of 3) Purpose-built door hangers designed to maintain privacy and create a more comfortable experience. Available in 2 sets of 3 unique double-sided hangers measuring 3.5" x 8.5", printed on sturdy cardstock with open slot design. Priced at $9.99 per set.
Quantifiable outcome
- Sample integrity maintained for up to 24 hours under defined conditions
- +2 more outcomes
Companies that use RSI Technology Group
Customer profileSegments3 records
Ideal customer profiles2 records
RSI Technology Group technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
RSI Technology Group partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core and minor.
- Families Out LoudcoreRSI partners with Families Out Loud (FOL), an organization supporting LGBTQIA+ families, as part of their commitment to inclusive fertility care. This partnership aligns with RSI's mission to support LGBTQIA+ individuals, couples, single parents by choice, and families with accessible, affirming, and equitable reproductive health solutions.
- Hann's Fertility PharmacyminorHann's Fertility Pharmacy is listed as a partner pharmacy on RSI's resources page, offering financing and pharmacy services for fertility care.
- Mandell's PharmacyminorMandell's Pharmacy is listed as a partner pharmacy on RSI's resources page, offering pharmacy services for fertility patients.
- Pixel Care HealthminorPixel Care Health is listed as a partner pharmacy/resource on RSI's resources page.
- Andrology Store by SpectrumminorAndrology Store by Spectrum is listed as a purchase partner for RSI products, specializing in andrology supplies for fertility clinics.
- Fertitech CanadaminorFertitech Canada is listed as a purchase partner, indicating RSI's presence in the Canadian fertility market.
- IVF StoreminorIVF Store is listed as a purchase partner offering ProteX products and related fertility supplies.
- CapExMDminorCapExMD is listed as a financing partner, providing fertility financing options for patients.
- PatientFiminorPatientFi is listed as a financing partner offering patient financing options for fertility treatments and products.
- Texas Tech University / Texas Tech Innovation HubcoreRSI licensed technology from Texas Tech University. The company was founded based on research by Dr. Samuel Prien, Dr. Dustie Johnson, and Dr. Lindsay Penrose from Texas Tech. RSI relaunched in 2017 through the Texas Tech Innovation Hub's Accelerator program, securing grants to bring products to market.
Scale indicators3 records
Recent moves2 records
Expansion highlights5 records
RSI Technology Group competitors and assessment
Company assessmentOthers
- Cryos International: Cryos International is one of the largest sperm banks globally and a customer/ecosystem participant in the fertility value chain; its reliance on sperm collection and handling logistics makes it an adjacent rather than direct competitor to RSI's devices.
Direct peers
- Genea Biomedx: Genea Biomedx develops and commercializes ART-focused medical devices and lab instruments for IVF and andrology clinics, overlapping directly with RSI's sperm preparation and handling product positioning.
- Hamilton Thorne: Hamilton Thorne designs and sells precision instruments and consumables for the fertility and ART market, including sperm analysis and preparation devices used in the same clinical workflow as RSI's NovoSort sperm isolation device.
- Rocket Medical: Rocket Medical manufactures medical devices for reproductive medicine and fertility procedures, including products used in sperm collection and ART workflows comparable to ProteX and NovoSort.
- Conceivex (The Stork): Conceivex markets The Stork, an at-home and OTC conception device; it overlaps with RSI's ProteX on the consumer-facing, at-home male fertility collection use case.
Broad incumbents
- CooperSurgical: CooperSurgical is a large incumbent in the fertility and reproductive medicine market, offering a broad portfolio of ART devices, consumables, and genetic testing services sold into the same fertility clinics and IVF centers that RSI targets with ProteX and NovoSort.
- FUJIFILM Irvine Scientific: FUJIFILM Irvine Scientific provides ART media, devices, and processing tools to fertility clinics worldwide, including sperm preparation consumables that compete with NovoSort's passive separation approach.
- Vitrolife: Vitrolife is a global ART products company supplying media, devices, and consumables for IVF and andrology labs; its products overlap directly with the sperm preparation and handling workflow where RSI's NovoSort competes.
Regional players
- Kitazato Corporation: Kitazato is a Japan-headquartered ART device and consumables manufacturer whose sperm preparation and cryopreservation products target the same IVF/andrology clinic workflow as RSI, though it primarily serves APAC markets.
Emerging players
- Sperm Processor Medical (Gynotec): Gynotec markets the Sperm Processor, a centrifuge-free sperm preparation device used in IUI/IVF clinics; it is a direct emerging competitor to NovoSort's passive separation approach.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
RSI Technology Group social profiles
Digital presenceRSI Technology Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
RSI Technology Group leadership team
Management profileNumber of profiles
Profiles8 records
RSI Technology Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
RSI Technology Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about RSI Technology Group
What does RSI Technology Group do?
RSI Technology Group designs, manufactures, and sells proprietary medical devices for sperm collection and preparation in fertility care. Its flagship products — the ProteX Semen Collection Cup with triple-layer insulation and Safe Seal, and the NovoSort passive, centrifuge-free Sperm Preparation Device — are sold as an integrated collection-to-preparation system to fertility clinics, IVF centers, and patients. Devices are priced per unit with bulk case discounts available and are sold through direct sales, the company's e-commerce site, and partner pharmacies.
Is RSI Technology Group a public or private company?
RSI Technology Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was RSI Technology Group founded?
RSI Technology Group was founded in 2009.
Where is RSI Technology Group based?
RSI Technology Group is headquartered in Frisco, United States, in the North America region.
How does RSI Technology Group make money?
One revenue line is on record: medical Device Sales.
Who are RSI Technology Group's main competitors?
Cryos International is listed as an others. Direct peers are Genea Biomedx, Hamilton Thorne, Rocket Medical and Conceivex (The Stork). Broad incumbents are CooperSurgical, FUJIFILM Irvine Scientific and Vitrolife. Kitazato Corporation is listed as a regional player. Sperm Processor Medical (Gynotec) is listed as an emerging player.
Does RSI Technology Group have an API?
No public API is recorded for RSI Technology Group.
What industry is RSI Technology Group in?
RSI Technology Group's product category is Fertility Medical Devices. Its primary akta.pro industry code is HLAKAOAD, Male Reproductive & Sexual Medicine (Andrology). Its NAICS code is 339112 and its SIC code is 3841.